Stay updated on Talquetamab Dose Escalation in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.

Latest updates to the Talquetamab Dose Escalation in Myeloma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe footer revision tag was updated to v3.6.5, indicating a new site release; it does not alter study information or how the page is used.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision label v3.6.4 was added to the history and the previous v3.6.3 label was removed, indicating a minor update to the page.SummaryDifference0.0%

- Check46 days agoChange DetectedThe latest version adds two new sections to the history view, Study Status and Study Identification, signaling updates to the trial's current status and identifiers. An entry on 2026-07-02 includes the value '85', and a prior deletion on 2026-06-05 indicates a removal from the history.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page history shows a revision change from v3.6.2 to v3.6.3. This indicates a minor internal update to the page version rather than changes to the study details or its presentation.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.6.2 was added and Revision: v3.6.0 was removed from the page history. This reflects a minor platform update rather than changes to the study record content.SummaryDifference0.0%

- Check74 days agoChange DetectedRecruitment for the study is no longer open to new participants. The record has been updated to revision v3.6.0, and the previous revision v3.5.5 has been removed.SummaryDifference0.2%

Stay in the know with updates to Talquetamab Dose Escalation in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.